Protagonist Therapeutics grants inducement equity awards for 7,175 shares to new hires at USD 155.1 strike pricePUBT·1 day ago, 03:05 PMPTGX-2.17%
Protagonist Therapeutics (NASDAQ:PTGX) CEO Sells 65,761 Shares of StockMarket Beat·Aug 13 at 05:23 AMPTGX-2.17%
Protagonist Therapeutics CEO Dinesh V. Patel disposes of USD 14.89 million in common sharesPUBT·Aug 12 at 05:44 PMPTGX-2.17%
This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Mondaybenzinga_article·Aug 10 at 07:07 AMNTAP+0.31%LECO-1.12%
Protagonist Therapeutics (PTGX) Swings To Net Income, Is The Valuation Too Expensive?Simplywall·Aug 9 at 10:38 PMPTGX-2.17%
Protagonist Therapeutics (PTGX) Stock Price Surges After Profit InflectionSimplywall·Aug 6 at 06:43 PMPTGX-2.17%
Protagonist Therapeutics, Inc. Stock 12‑Month Price Target Raised to $152.14, Implies 11% UpsideTradingView·Aug 6 at 06:20 PMPTGX-2.17%
Citigroup Forecasts Strong Price Appreciation for Protagonist Therapeutics (NASDAQ:PTGX) StockMarket Beat·Aug 6 at 03:12 PMPTGX-2.17%STT+0.42%
Protagonist Therapeutics shares are trading higher after Barclays raised its price target on the stock from $151 to $153.benzinga_article·Aug 6 at 12:41 PMPTGX-2.17%
Protagonist Therapeutics (NASDAQ:PTGX) Hits New 12-Month High Following Strong EarningsMarket Beat·Aug 6 at 09:20 AMPTGX-2.17%NA+0.10%
Protagonist returns to profit in Q2 FY26 with net income of $162.85 millionPUBT·Aug 5 at 03:23 PMPTGX-2.17%TAK-0.79%
Protagonist Therapeutics grants new hires options for 7,300 shares, RSUs for 1,975 shares at $136.64 strike pricePUBT·Aug 4 at 03:52 PMPTGX-2.17%
Protagonist Therapeutics (PTGX) Projected to Post Earnings on WednesdayMarket Beat·Jul 29 at 08:11 AMPTGX-2.17%
